CIM
IMUX icon

Cambria Investment Management’s Immunic IMUX Stock Holding History

Cambria Investment Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6
Closed -$47K – 342
2015
Q2 		$47K Buy
6
+5
+500% +$47.7K 0.01% 176
2015
Q1 		$10K Buy
+1
New +$9.19K ﹤0.01% 170

Other funds holding IMUX

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cambria Investment Management's IMUX Position: Q3 2015 in Review

Cambria Investment Management sold out of Immunic (IMUX) in Q3 2015, closing a stake of 6 shares — an estimated $47K sold.

Cambria Investment Management first reported a position in IMUX in Q1 2015 and held it in 2 quarters. The position peaked at $47K in Q2 2015. 56 funds tracked by Wall St. Rank hold IMUX as of Q3 2015.

  • Cambria Investment Management reported no remaining Immunic position as of Q3 2015 after selling out during the quarter.
  • Cambria Investment Management sold 6 Immunic shares in Q3 2015, an estimated $47K.
  • Cambria Investment Management first reported a position in Immunic in Q1 2015 and held it in 2 quarters.
  • Cambria Investment Management's Immunic position peaked at $47K in Q2 2015.
  • 56 funds tracked by Wall St. Rank held Immunic as of Q3 2015.

Based on Cambria Investment Management's 13F filing for Q3 2015, filed 2 Nov 2015.